Literature DB >> 33432200

Metabolic Messengers: glucagon-like peptide 1.

Fiona M Gribble1, Frank Reimann2.   

Abstract

Glucagon like peptide-1 (GLP-1), a peptide hormone from the intestinal tract, plays a central role in the coordination of postprandial glucose homeostasis through actions on insulin secretion, food intake and gut motility. GLP-1 forms the basis for a variety of current drugs for the treatment of type 2 diabetes and obesity, as well as new agents currently being developed. Here, we provide a concise overview of the core physiology of GLP-1 secretion and action, and the role of the peptide in human health, disease and therapeutics.

Entities:  

Year:  2021        PMID: 33432200     DOI: 10.1038/s42255-020-00327-x

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  94 in total

1.  On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane.

Authors:  B Moore
Journal:  Biochem J       Date:  1906       Impact factor: 3.857

Review 2.  Function and mechanisms of enteroendocrine cells and gut hormones in metabolism.

Authors:  Fiona M Gribble; Frank Reimann
Journal:  Nat Rev Endocrinol       Date:  2019-04       Impact factor: 43.330

3.  Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

Authors:  M A Nauck; N Kleine; C Orskov; J J Holst; B Willms; W Creutzfeldt
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

Review 4.  The physiology of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

5.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Authors:  B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Endocrine cells in human intestine: an immunocytochemical study.

Authors:  K Sjölund; G Sandén; R Håkanson; F Sundler
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

7.  Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line.

Authors:  P L Brubaker; J Schloos; D J Drucker
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

8.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 9.  Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium.

Authors:  Fiona M Gribble; Frank Reimann
Journal:  Annu Rev Physiol       Date:  2015-10-06       Impact factor: 19.318

10.  Selective stimulation of colonic L cells improves metabolic outcomes in mice.

Authors:  Jo E Lewis; Emily L Miedzybrodzka; Rachel E Foreman; Orla R M Woodward; Richard G Kay; Deborah A Goldspink; Fiona M Gribble; Frank Reimann
Journal:  Diabetologia       Date:  2020-04-27       Impact factor: 10.122

View more
  18 in total

1.  The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.

Authors:  Zi-Yang Yi; Lin Chen; Yan Wang; Dan He; Di Zhao; Shui-Han Zhang; Rong Yu; Jian-Hua Huang
Journal:  Acta Diabetol       Date:  2022-07-20       Impact factor: 4.087

2.  The Influence of Obesity on Small Bowel Capsule Endoscopy.

Authors:  Teppei Omori; Yu Sasaki; Miki Koroku; Harutaka Kambayashi; Shun Murasugi; Maria Yonezawa; Shinichi Nakamura; Katsutoshi Tokushige
Journal:  Gastroenterol Res Pract       Date:  2022-05-09       Impact factor: 1.919

3.  Bidirectional effects of estradiol on the control of water intake in female rats.

Authors:  Jessica Santollo; Andrea A Edwards; Julia A Howell; Katherine E Myers
Journal:  Horm Behav       Date:  2021-05-18       Impact factor: 3.492

Review 4.  Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how.

Authors:  Kaijian Hou; Shuo Zhang; Zezhen Wu; Dan Zhu; Fengwu Chen; Zi-Ning Lei; Weiting Liu; Chuanxing Xiao; Zhe-Sheng Chen
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

Review 5.  Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics.

Authors:  Anita Kabahizi; Briana Wallace; Linh Lieu; Dominic Chau; Yanbin Dong; Eun-Sang Hwang; Kevin W Williams
Journal:  Br J Pharmacol       Date:  2021-11-04       Impact factor: 8.739

Review 6.  Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes.

Authors:  Anand-Krishna Singh; Dhananjay Yadav; Neha Sharma; Jun-O Jin
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

Review 7.  The Interplay between Nutrition, Innate Immunity, and the Commensal Microbiota in Adaptive Intestinal Morphogenesis.

Authors:  Franziska Bayer; Olga Dremova; My Phung Khuu; Könül Mammadova; Giulia Pontarollo; Klytaimnistra Kiouptsi; Natalia Soshnikova; Helen Louise May-Simera; Kristina Endres; Christoph Reinhardt
Journal:  Nutrients       Date:  2021-06-26       Impact factor: 5.717

Review 8.  GLP-1a: Going beyond Traditional Use.

Authors:  Lucas Fornari Laurindo; Sandra Maria Barbalho; Elen Landgraf Guiguer; Maricelma da Silva Soares de Souza; Gabriela Achete de Souza; Thiago Marques Fidalgo; Adriano Cressoni Araújo; Heron F de Souza Gonzaga; Daniel de Bortoli Teixeira; Thais de Oliveira Silva Ullmann; Katia Portero Sloan; Lance Alan Sloan
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

Review 9.  Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating.

Authors:  Daniel I Brierley; Guillaume de Lartigue
Journal:  Br J Pharmacol       Date:  2021-07-31       Impact factor: 8.739

10.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.